Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 1148-1153

  Aye, Thein Thein ^a   Bartholomeusz, Angeline ^a   Shaw, Tim ^a   Bowden, Scott ^a   Breschkin, Alan ^a   McMillan, Janine ^a   Angus, Peter ^a   Locarnini, Stephen ^a  

^a FAIRFIELD HOSPITAL   (Australia)

Author keywords

Famciclovir; Hepatitis B virus; Penciclovir; Viral polymerase

Indexed keywords

FAMCICLOVIR; FOSCARNET; GANCICLOVIR; PENCICLOVIR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRION; VIRUS MUTATION;

EID: 0030905343     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80125-0     Document Type: Article

References (20)

1. Vere Hodge RA. Review: antiviral portraits series, number 3. Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem Chemother. 4:1993;67-84.
2. Boyd MR, Safrin S, Kern ER. Penciclovir: a review of its spectrum of activity, selectivity and cross-resistance pattern. Antiviral Chem Chemother. 32:1987;358-363.
3. Shaw T, Amor P, Civitico G, Boyd M, Locarnini S. In vivo antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob Agents Chemother. 38:1994;719-723.
4. Shaw T, Mok SS, Locarnini SA. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Hepatology. 24:1996;. in press.
5. Tsiquaye KN, Slomka Mj, Maung M. Oral famciclovir against duck hepatitis B virus replication in hepatic and non-hepatic tissues of ducklings infected in ovo. J Med Virol. 42:1994;306-310.
6. Boker KHW, Ringe B, Kruger M, Pichlmayr R, Manns MP. Prostaglandin E plus famciclovir: a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation. 57:1994;1706-1708.
7. Angus P, Richards M, Bowden S, Ireton J, Jones B, Locarnini S. Combination chemotherapy controls post-liver transplant recurrence of hepatitis B virus infection. Gastroenterol Hepatol. 8:1993;353-357.
8. Price PM, Banejrjee R, Jeffrey AM, Acs G. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2′ deoxyguanosine. Hepatology. 16:1992;8-13.
9. Summers J, Mason W. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell. 29:1982;403-415.
10. Delarue M, Poch O, Tordo T, Moras D, Argos P. An attempt to unify the structure of polymerase. Protein Eng. 3:1990;461-467.
11. Poch O, Sauvaget I, Delarue M, Tordo N. Identification of four conserved motifs among the RNA dependent polymerase encoding elements. EMBO J. 8:1989;3867-3874.
12. Chiou HC, Kumura K, Hu A, Kerns KM, Coen DM. Penciclovir-resistance mutations in the herpes simplex virus DNA polymerase gene. Antiviral Chem Chemother. 6:1995;281-288.
13. Larder BA, Kemp SD, Darby G. Related functional domains in virus DNA polymerases. EMBO J. 6:1987;169-175.
14. Howard C. The structure of hepatitis B envelope and molecular variants of hepatitis B virus. J Viral Hepatitis. 2:1995;165-170.
15. Severini A, Liu XY, Wilson JS, Tyrrell DLJ. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-β-L-2′-3′-dideoxy-3′- thiacytidine. Antimicrob Agents Chemother. 39:1995;1430-1435.
16. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 333:1995;1657-1661.
17. Kruger T, Tillman HL, Trautwein C, Oldhafer K, Boker KHW, Pichlmeyer R, Manns MP. Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver transplantation. Hepatology. 22:1995;219A.
18. Main J, Brown JL, Howells C, Galassini R, Crossey M, Karayiannis P, Georgiou P, Atkinson G, Thomas HC. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis. 3:1996;211-215.
19. Ling R, Mutimer D, Ahmed M, Boxall EH, Ellas E, Dusheiko GM, Harrison T. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology. 24:1996;711-713.
20. Tisdale M, kemp SD, Parry NR, Larder BA. Rapid in vivo selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci USA. 90:1993;5653-5656.